Champion Bio Changping Life Science Valley Industrial Base Files Prospectus for 430,000-Square-Meter Medical and Health Industrial Park in Beijing

Recently, the Changping Life Valley Industrial Base launched the construction of its third and fourth phases. Through industrial planning, brand upgrading, and service iteration, it aims to create a one-stop innovative industrial ecosystem park with a comprehensive sci-tech innovation system and a complete industrial chain, spanning from R&D and headquarters offices to industrialization bases, thereby enhancing the region’s capacity to host high-end, cutting-edge projects in the pharmaceutical and healthcare sectors.

The industrial base has a total planned area of approximately 430,000 square meters and is developed in four phases. Phases I and II were converted from the existing Zhongke Yungu Park. The 200,000-square-meter space has already attracted renowned biomedical enterprises such as SunNovo, Increase Pharmaceutical, and Pins Medical, as well as high-tech enterprises including Linktech Navi, China Tower Beijing Branch, and Zhixin Technology.

Phases III and IV are currently under planning and construction, integrating the concept of “production, living, and ecology.” By attracting various innovative enterprises and teams, pharmaceutical professionals, local and non-local pharmaceutical companies, and supporting industry operators to settle in the park, we will provide resident enterprises with a comprehensive suite of core and supporting services—ranging from office space to R&D, from production to daily living, and from logistics to finance. We are committed to continuously improving service quality, fostering the integrated development of upstream, midstream, and downstream industries, and cultivating and refining the innovation chain within the pharmaceutical and health sector.

In the future, the Changping Life Valley Industrial Base will become a crucial link in bridging basic research with production and commercialization. By developing high-quality spaces for biopharmaceutical R&D and industrialization, supported by comprehensive pilot-scale testing centers and integrated solutions for biopharmaceutical R&D, along with specialized industrial service systems and industry funds, it aims to create a high-quality ecosystem for innovative development in the pharmaceutical and healthcare sectors.